Form 4: Calumet Director Karen Narwold Granted 7,067 Restricted Stock Units
Insider Transaction Report
Calumet, Inc. director Karen G. Narwold was granted 7,067 Restricted Stock Units (RSUs) on June 11, 2025, as part of her compensation.
Summary
- Karen G. Narwold, a Director of Calumet, Inc. (CLMT), was granted 7,067 Restricted Stock Units (RSUs) on June 11, 2025.
- Each RSU is economically equivalent to one share of Calumet, Inc. common stock, par value $0.01 per share.
- The RSUs were acquired at a price of $0, indicating they were a grant rather than a purchase.
- Following this transaction, Ms. Narwold beneficially owns 7,067 derivative securities (RSUs) directly.
- The Restricted Stock Units are scheduled to vest upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026.
- Upon vesting, the Restricted Stock Units will be settled.
Sentiment
Score: 7
Explanation: The grant of Restricted Stock Units to a director is generally a positive signal as it aligns the director's interests with shareholder value, indicating commitment and incentivizing long-term performance. It is a standard compensation practice.
Positives
- The grant of Restricted Stock Units to a director aligns the director's interests with those of the shareholders, as the value of the compensation is tied to the company's stock performance.
- This type of equity compensation is a common practice for retaining and incentivizing board members.
Risks
- The value of the granted Restricted Stock Units is subject to the future performance of Calumet, Inc.'s common stock; a decline in stock price before vesting would reduce the ultimate value received by the director.
Future Outlook
The granted Restricted Stock Units are set to vest upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026, at which point they will be settled.
Industry Context
This Form 4 filing is a standard disclosure of an insider equity grant, common across all industries for executive and director compensation, aiming to align management and board interests with shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Compensation | Grant of 7,067 Restricted Stock Units to Director Karen G. Narwold as part of her compensation package. | 06/11/2025 | This grant aligns the director's financial interests with the long-term performance of Calumet, Inc.'s stock, enhancing corporate governance by incentivizing value creation for shareholders. |
Related Party Transactions
- The grant of 7,067 Restricted Stock Units to Karen G. Narwold, a Director of Calumet, Inc., constitutes a related party transaction as it involves compensation provided by the company to a member of its board.
Stakeholder Impact
- Shareholders: The grant of RSUs, while a form of compensation, can lead to minor dilution upon settlement, but primarily aims to align the director's interests with shareholder value creation.
- Employees: No direct impact on general employees is indicated by this specific filing.
- Director (Karen G. Narwold): Receives equity compensation that vests over time, tying her personal financial outcome to the company's stock performance.
Next Steps
- Vesting of the 7,067 Restricted Stock Units upon the earlier of June 11, 2026, or the date of Calumet, Inc.'s Annual Meeting in 2026.
- Settlement of the Restricted Stock Units upon vesting.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of transaction where 7,067 Restricted Stock Units were acquired by Karen G. Narwold. |
| 06/13/2025 | Date the Form 4 was signed by Connor J. Egan, as attorney-in-fact for Karen G. Narwold. |
| 06/11/2026 | Earliest date on which the Restricted Stock Units will vest. |
| 2026 | Year of Calumet, Inc.'s Annual Meeting, which is an alternative vesting trigger for the Restricted Stock Units. |
Keywords
Calumet Inc., CLMT, Restricted Stock Units, RSU, Director compensation, SEC Form 4, Insider transaction, Equity grant, Corporate governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.